Meeting
2021 ASCO Annual Meeting
Treatment-specific risk of second malignancies in five-year survivors of diffuse large B-cell lymphoma.
Authors
Yvonne M. Geurts
Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, Netherlands
Yvonne M. Geurts , Suzanne I.M. Neppelenbroek , Cynthia So-Osman , Joost S.P. Vermaat , Dick Johan van Spronsen , Wouter J. Plattel , Roel J. de Weijer , Karijn M.S. Verschueren , Josée M. Zijlstra , Harry R. Koene , Marten R. Nijziel , Erik C. Schimmel , Lara H. Böhmer , Francisca Ong , Hein Visser , Daphne van Kampen , Marie José Kersten , Berthe M.P. Aleman , Flora Van Leeuwen , Michael Schaapveld
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Symptoms and Survivorship
Track
Symptom Science and Palliative Care
Sub Track
Late and Long-Term Adverse Effects
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 12072)
DOI
10.1200/JCO.2021.39.15_suppl.12072
Abstract #
12072
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2018 ASCO Annual Meeting
Incidence and risk of second primary malignancy after an index potentially-human papillomavirus-associated cancer.
First Author: Eric Adjei Boakye
Poster
2018 Gastrointestinal Cancers Symposium
Second primary cancers and recurrence in patients after resection of colorectal cancer: An integrated analysis of trials by Japan Clinical Oncology Group: JCOG0205, JCOG0212, JCOG0404 (JCOG1702A).
First Author: Kiyo Tanaka
First Author: Raji Shameem
Poster
2024 ASCO Genitourinary Cancers Symposium
Secondary primary malignancies among patients with GU cancer.
First Author: Nikita Tripathi